EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device— 510(k) K212908

Substantially Equivalent

Neuravi, Ltd.

FDA 510(k) clearance K212908 for EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device, Substantially Equivalent on 2021-10-13. Applicant: Neuravi, Ltd..

Clearance details

Applicant: Neuravi, Ltd.
Product code: Code NRY
Advisory panel: Cardiovascular
Date received: 2021-09-13
Decision date: 2021-10-13
Decision: Substantially Equivalent
Clearance type: Special
Location: Galway, IE

Download summary PDF View on FDA.gov ↗

Adverse events under product code NRY

product code NRY

Death: 411
Injury: 1,712
Malfunction: 1,855
Total: 3,978

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.